Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 13692297

Potassium replacement therapy.

G N CHANDLER·C HETHERINGTON·A N STEPHENSON·M ATKINSON
View original source ↗Export metadata ↓

Abstract

Potassium replacement is often an important therapeutic measure, and the advantages of effervescing potassium-containing granules are put forward in this article.

Explore related subjects

Biological TherapyHumansHypokalemiaPotassiumPotassium DeficiencyPOTASSIUM/deficiencyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G N CHANDLER, C HETHERINGTON, A N STEPHENSON, M ATKINSON. 1961. Potassium replacement therapy.. https://doi.org/10.1136/gut.2.2.186

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.

Primary cutaneous T-cell lymphomas represent a wide variety of non-Hodgkin lymphomas that are characterized by a distinct clinical presentation. Advanced molecular and biological techniques have enhanced the recognition of cutaneous T-cell lymphomas. The most common subtypes of cutaneous T-cell lymphomas are the epidermotropic variants mycosis fungoides and Sézary syndrome. At present, a stage-adjusted therapy is the best concept available, since early aggressive treatment options did not improve the prognosis of patients with cutaneous T-cell lymphomas. Accurate diagnostic and clinical assessment as well as identification of prognostic factors provides a helpful basis for treatment strategies. Current medical literature on diagnosis, prognosis, and treatment is reviewed with emphasis on new biologic response-modifying treatment options.

Biological Therapy↗
PubMed2003

Biological therapy in Crohn's disease.

The discovery of the central role of tumour necrosis factor-alpha in Crohn's disease and the subsequent introduction of infliximab into routine clinical practice has transformed the treatment of refractory disease. Advances in understanding of the immunopathological basis of Crohn's disease are leading to the development of new biological therapies which are likely to play an increasing role in future.

Biological Therapy↗